Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asa E Radix

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Lancet. HIV|March 30, 2025
HIV seropositivity and viral non-suppression in transgender, non-binary, and gender-diverse people in primary care receiving gender-affirming hormone therapy in the USA between 2013 and 2019 (LEGACY): an observational, longitudinal, cohort studySari L Reisner, David R Pletta, Kenneth H Mayer, et al.
Psychoneuroendocrinology|July 14, 2026
Discrimination, chronic stress, and multimorbidity in cohort of Black and Latina transgender women with HIV: Longitudinal findings from the LITE Plus studyTonia C Poteat, Robert-Paul Juster, L Zachary DuBois, et al.
Clinical Chemistry|December 20, 2021
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic ReviewMark A Marzinke, Dina N Greene, Patrick M Bossuyt, et al.
American Journal of Preventive Medicine|October 10, 2024
Hormones, Stress, and Heart Disease in Transgender Women with HIV in LITE PlusTonia C Poteat, Molly Ehrig, Hedyeh Ahmadi, et al.
AJPM Focus|March 7, 2025
Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite CohortErin E Cooney, Sari L Reisner, Tonia C Poteat, et al.
BMC Public Health|January 20, 2024
Access to healthcare among transgender women living with and without HIV in the United States: associations with gender minority stress and resilience factorsTalia A Loeb, Sarah M Murray, Erin E Cooney, et al.
Journal of the International AIDS Society|December 19, 2025
The persistent chasm between PrEP awareness and uptake: characterizing the biomedical HIV prevention continuum in a nationwide cohort of transgender women in the United States and Puerto RicoErin E Cooney, Tonia C Poteat, Meg Stevenson, et al.
AIDS and Behavior|December 5, 2024
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE StudyErin E Cooney, Meg Stevenson, Rodrigo A Aguayo-Romero, et al.
Journal of the International AIDS Society|December 20, 2023
PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort studyErin E Cooney, Haneefa T Saleem, Meg Stevenson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2025
Clinical Outcomes of Mpox Disease in Patients Treated with TecovirimatCiarra Leocadio, Elizabeth Garcia, Maura Lash, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Lancet. HIV|March 30, 2025
HIV seropositivity and viral non-suppression in transgender, non-binary, and gender-diverse people in primary care receiving gender-affirming hormone therapy in the USA between 2013 and 2019 (LEGACY): an observational, longitudinal, cohort studySari L Reisner, David R Pletta, Kenneth H Mayer, et al.
Psychoneuroendocrinology|July 14, 2026
Discrimination, chronic stress, and multimorbidity in cohort of Black and Latina transgender women with HIV: Longitudinal findings from the LITE Plus studyTonia C Poteat, Robert-Paul Juster, L Zachary DuBois, et al.
Clinical Chemistry|December 20, 2021
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic ReviewMark A Marzinke, Dina N Greene, Patrick M Bossuyt, et al.
American Journal of Preventive Medicine|October 10, 2024
Hormones, Stress, and Heart Disease in Transgender Women with HIV in LITE PlusTonia C Poteat, Molly Ehrig, Hedyeh Ahmadi, et al.
AJPM Focus|March 7, 2025
Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite CohortErin E Cooney, Sari L Reisner, Tonia C Poteat, et al.
BMC Public Health|January 20, 2024
Access to healthcare among transgender women living with and without HIV in the United States: associations with gender minority stress and resilience factorsTalia A Loeb, Sarah M Murray, Erin E Cooney, et al.
Journal of the International AIDS Society|December 19, 2025
The persistent chasm between PrEP awareness and uptake: characterizing the biomedical HIV prevention continuum in a nationwide cohort of transgender women in the United States and Puerto RicoErin E Cooney, Tonia C Poteat, Meg Stevenson, et al.
AIDS and Behavior|December 5, 2024
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE StudyErin E Cooney, Meg Stevenson, Rodrigo A Aguayo-Romero, et al.
Journal of the International AIDS Society|December 20, 2023
PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort studyErin E Cooney, Haneefa T Saleem, Meg Stevenson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2025
Clinical Outcomes of Mpox Disease in Patients Treated with TecovirimatCiarra Leocadio, Elizabeth Garcia, Maura Lash, et al.
Pageof 6